Publicaciones en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (102)

2024

  1. Chronic obstructive pulmonary disease mortality in Spain between 1999 and 2019

    Medicina Clinica, Vol. 162, Núm. 1, pp. 9-14

  2. Detection of Alpha-1 Antitrypsin Levels in Chronic Obstructive Pulmonary Disease in Respiratory Clinics in Spain: Results of the EPOCONSUL 2021 Audit

    Journal of Clinical Medicine, Vol. 13, Núm. 4

2023

  1. Characteristics of individuals with alpha-1 antitrypsin deficiency from Northern and Southern European countries: EARCO international registry

    The European respiratory journal

  2. Correction: Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry (Respiratory Research, (2022), 23, 1, (352), 10.1186/s12931-022-02275-4)

    Respiratory Research

  3. Inhaled Maintenance Therapy in the Follow-Up of COPD in Outpatient Respiratory Clinics. Factors Related to Inhaled Corticosteroid Use. EPOCONSUL 2021 Audit

    Archivos de Bronconeumologia, Vol. 59, Núm. 11, pp. 725-735

  4. Recommendations for the Implementation of the Self-Administration of Alpha-1 Antitrypsin

    International Journal of COPD, Vol. 18, pp. 1691-1700

  5. Treatment Patterns of Monoclonal Antibodies in Patients With Severe Uncontrolled Asthma Treated by Pulmonologists in Spain

    Open Respiratory Archives, Vol. 5, Núm. 3

  6. Variations in Chronic Obstructive Pulmonary Disease Outpatient Care in Respiratory Clinics: Results From the 2021 EPOCONSUL Audit

    Archivos de Bronconeumologia, Vol. 59, Núm. 5, pp. 295-304

2022

  1. A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases

    International Journal of Technology Assessment in Health Care, Vol. 38, Núm. 1

  2. ANTES Program: One Year on

    Archivos de Bronconeumologia

  3. Author Correction: Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension (Scientific Reports, (2022), 12, 1, (5289), 10.1038/s41598-022-09353-z)

    Scientific Reports

  4. Clinical Characteristics, Treatment Persistence, and Outcomes Among Patients With COPD Treated With Single- or Multiple-Inhaler Triple Therapy: A Retrospective Analysis in Spain

    Chest, Vol. 162, Núm. 5, pp. 1017-1029

  5. Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry

    Respiratory Research, Vol. 23, Núm. 1

  6. Demographic and clinical characteristics of patients with α1-antitrypsin deficiency genotypes PI*ZZ and PI*SZ in the Spanish registry of EARCO

    ERJ Open Research, Vol. 8, Núm. 3

  7. Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension

    Scientific reports, Vol. 12, Núm. 1, pp. 5289

  8. Knowledge and role of dermatologists in life-threatening infections: a national survey among hospital skin specialists

    Journal of the European Academy of Dermatology and Venereology

  9. Monoclonal antibody treatment for severe uncontrolled asthma in Spain: analytical map

    Journal of Asthma, Vol. 59, Núm. 10, pp. 1997-2007

  10. Pulmonologists’ Opinion on the Use of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease Patients in Spain: A Cross-Sectional Survey

    International Journal of COPD, Vol. 17, pp. 1577-1587

  11. T2 Biomarkers as Predictors of Exacerbations of Chronic Obstructive Pulmonary Disease

    Archivos de Bronconeumologia, Vol. 58, Núm. 8, pp. 595-600

  12. The Effect of Clusters of Double Triggering and Ineffective Efforts in Critically Ill Patients

    Critical Care Medicine, Vol. 50, Núm. 7, pp. E619-E629